
E-mail:mossinev@missouri.edu
Office: 4 Agriculture Building
Mail: Biochemistry
4 Agriculture Building
University of Missouri
Columbia, MO 65211
Phone: 573-882-2608
Fax: 573-884-9676
| Degree | School | Location | Major |
| B.Sc. | Kiev State University | Ukraine | Chemistry and Math |
| M.Sc. | Kiev State University | Ukraine | Analytic Chemistry |
| PhD | Academy of Science of Ukraine | Ukraine | Bioinorganic Chemistry |
Download (PDF)
Carbohydrate chemistry and biochemistry. Carbohydrate-based anti-tumor agents. Maillard reaction in foods and in vivo.
Glinsky, V.V., Kiriakova, G., Glinskii, O.V., Mossine, V.V., Mawhinney, T.P., Turk, J.R., Glinskii, A.B., Huxley, V.H., Price, J.E., and Glinsky, G.V. (2009) Synthetic galectin-3 inhibitor increases metastatic cancer cell sensitivity to taxol-induced apoptosis in vitro and in vivo. Neoplasia, 11: 901-909.
Mossine, V.V., Barnes, C.L., Chance, D.L. and Mawhinney, T.P. (2009) Stabilization of the acyclic tautomer in reducing carbohydrates. Angewandte Chemie, 121: 5625-5628.
Mossine, V.V., Barnes, C.L., and Mawhinney, T.P. Disordered hydrogen bonding in N-(1-deoxy-beta-d-fructopyranos-1-yl)-N-allylaniline. Carbohydrate Research 344, 948-951(2009).
Liu, S.D., Whiting, C.C., Tomassian, T., Pang, M., Bissel, S.J., Baum, L.G., Mossine, V.V., Poirier, F., Huflejt, M.E., Miceli, M.C. (2008) Endogenous galectin-1 enforces class I-restricted TCR functional fate decisions in thymocytes. Blood, 112: 120-130.
Mossine, V.V., Chopra, P., and Mawhinney, T.P. (2008) Interaction of tomato lycopene and ketosamine against rat prostate tumorigenesis. Cancer Research 68, 4384-4391.
Mossine, V.V. and Mawhinney, T.P. (2007).Nα-(1-Deoxy-D-fructos-1-yl)-L-histidine ("D-Fructose-L-histidine"): a Potent Copper Chelator from Tomato Powder. J. Agric. Food Chem., 55:10373-10381.
Johnson, K.D., Glinskii, O.V., Mossine, V.V., Turk, J.R., Mawhinney, T.P., Anthony, D.C., Henry, C.J., Huxley, V.H., Glinsky, G.V., Pienta, K.J.; Raz, A. and Glinsky, V.V. (2007) Galectin-3 as a potential therapeutic target in tumors arising from malignant endothelia. Neoplasia, 9(8), 662-670.